{"id":105743,"name":"BAVARIAN NORDIC WASHINGTON, DC, INC.","slug":"bavarian-nordic-washington-dc-inc","state":"DC","country":"United States of America","description":"Pharmaceutical company","totalSpending":570000,"filings":26,"yearlySpending":[{"year":2018,"income":70000},{"year":2019,"income":60000},{"year":2020,"income":60000},{"year":2021,"income":100000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":40000}],"issues":["HCR"],"firms":["BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ"],"lobbyists":["NICOLE CARELLI","THOMAS DASCHLE"],"govEntities":["SENATE","White House Office","Office of Management & Budget (OMB)","HOUSE OF REPRESENTATIVES","Executive Office of the President (EOP)"],"sampleDescriptions":["Authorization and appropriations for medical countermeasures development and procurement.","Authorization and appropriations for medical countermeasures development and procurement.","H.R. 6378/S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act.","H.R. 269, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, provisions related to authorization for medical countermeasures development and procurement; medical counterme","H.R. 269, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 and S. 1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, provisions related to "],"years":[2018,2019,2020,2021,2022,2023,2024]}